<<

Clinical Sessions for Recertification: Geriatric

** Materials for this course will be release on 12/16/2020 ** ______

Clinical Sessions for Recertification: Geriatric Pharmacy (Cert # L209331)

Teaser: The Geriatric Pharmacy Clinical Sessions for Recertification Package consists of 4 activities and provides up to 5.0 hours of recertification credit through a high-level, interactive discussion on contemporary and emerging issues in ambulatory care pharmacy.

Tag: Certifications; Geriatric

ACPE Numbers: 0204-9999-20-292-H01-P 0217-9999-20-121-H01-P 0204-9999-20-319-H01-P 0204-9999-20-320-H01-P

Pre-Sale Date: 11/18/2020 Content Release Date: 12/16/2020 Expiration Date: 12/14/2021 Activity Type: Application-based CE Credits: 5.0 hours Activity Fee: $150 (ASHP member); $250 (non-member)

Accreditation for The American Society of -System Pharmacists and the American College of Clinical Pharmacy are accredited by the Accreditation Council for Pharmacy as a providers of continuing pharmacy education.

Target Audience These recertification activities are intended for board certified pharmacists seeking to update their knowledge and skills in: • Geriatrics • Ambulatory Care • Women’s Health • Secondary Stroke Prevention • Cognitive Impairment • Sepsis

Activity Overview The Clinical Sessions Package is intended for board certified pharmacists in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS). Using a case-based approach, the activities provide high-level, interactive discussions on contemporary and emerging issues in geriatric pharmacy.

The Geriatric Pharmacy Clinical Sessions Recertification Package consists of 4 activities (see table below) and provides up to 5.0 hours of continuing pharmacy education and/or recertification credit.

Copyright © 2020, American College of Clinical Pharmacy, Inc. and American Society of Health-System Pharmacists All rights reserved.

Clinical Sessions for Recertification: Geriatric Pharmacy

** Materials for this course will be release on 12/16/2020 ** ______

These activities are part of the ASHP and ACCP professional development program for BCGP recertification approved by the BPS. For pharmacists who maintain more than one certification, three of the activities are approved for multiple specialties (see table below).

Recertification Credit* Board certified pharmacists are eligible to receive up to 5.0 hours of recertification credit for completing this package. To earn recertification credit, learners must review the activity content and successfully complete the online assessments by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.

Recertification credit is earned in the calendar year in which you pass the recertification assessment.

Credit *Assessment Learning Module ACPE Number Specialty Hours Pass Point Managing Sepsis in the Older Adult 0204-9999-20-292-H01-P 1.00 BCGP TBD An Unforgettable Session: The 's Role in Mild Cognitive 0217-9999-20-121-H01-P 1.5 BCGP, BCACP TBD Impairment Not so FAST – Engaging in SLOW Decision Making for Secondary Stroke 0204-9999-20-319-H01-P 1.5 BCGP, BCACP TBD Prevention Managing Menopause: A "Hot" Topic 0204-9999-20-320-H01-P 1 BCGP, BCACP TBD

Managing Sepsis in the Older Adult ACPE Number: 0204-9999-20-292-H01-P Learning Objectives At the conclusion of this application-based educational activity, participants should be able to do the following: • Describe physiologic changes in the older adult that affect early identification of sepsis. • Evaluate the current literature, including the Surviving Sepsis Campaign, regarding treatment recommendations for sepsis in older adults. • Design a treatment strategy for sepsis in the older adult. This activity is approved for Board Certified Geriatric Pharmacist (BCGP) recertification credit.

An Unforgettable Session: The Pharmacist's Role in Mild Cognitive Impairment ACPE Number: 0217-9999-20-121-H01-P Learning Objectives At the conclusion of this application-based educational activity, participants should be able to do the following: • Demonstrate appropriate use of a screening tool for cognitive impairment. • Determine potentially reversible causes of cognitive impairment, including potentially inappropriate medication use in this population. • Develop evidence-based and -centered treatment plans for older adults with mild cognitive impairment. This activity is approved for Board Certified Ambulatory Care Pharmacist (BCACP) and Board Certified Geriatric Pharmacist (BCGP) recertification credit.

Copyright © 2020, American College of Clinical Pharmacy, Inc. and American Society of Health-System Pharmacists All rights reserved.

Clinical Sessions for Recertification: Geriatric Pharmacy

** Materials for this course will be release on 12/16/2020 ** ______

Not so FAST – Engaging in SLOW Decision Making for Secondary Stroke Prevention ACPE Number: 0204-9999-20-319-H01-P Learning Objectives At the conclusion of this application-based educational activity, participants should be able to do the following: • Evaluate literature that defines secondary stroke treatment goals, including prevention, to the care of older adults. • Identify clinical situations for secondary stroke prevention where life expectancy, functional status, patient preference or goals of care should override standard recommendations for screening/treatment. • Recommend secondary stroke prevention strategies for older adult with multiple conditions, including hypertension, dyslipidemia, atrial fibrillation, tobacco use disorder, diabetes, and hormone deficiency. This activity is approved for Board Certified Ambulatory Care Pharmacist (BCACP) and Board Certified Geriatric Pharmacist (BCGP) recertification credit.

Managing Menopause: A "Hot" Topic ACPE Number: 0204-9999-20-320-H01-P Learning Objectives At the conclusion of this application-based educational activity, participants should be able to do the following: • Describe the spectrum of symptoms present in a perimenopausal female. • Analyze the risk/benefit ratio of hormonal for the management of perimenopausal symptoms. • Recommend therapeutic regimens for the management of perimenopausal vasomotor symptoms. • Select for the management of postmenopausal osteoporosis taking into account guideline recommendations from the National Osteoporosis Foundation, The North American Menopause Society, and The Endocrine Society. This activity is approved for Board Certified Ambulatory Care Pharmacist (BCACP) and Board Certified Geriatric Pharmacist (BCGP) recertification credit.

Faculty (https://www.rxcertifications.org/Geriatric/Course-Faculty) Gina Ayers, Pharm.D., BCGP, BCPS Geriatrics Clinical Pharmacy Specialist Center for Geriatric Medicine Cleveland Clinic Cleveland, Ohio

Noll Campbell, Pharm.D., FASCP, BCPP Assistant Professor for Pharmacy Practice Purdue University West Lafayette, Indiana

Steven Pass, Pharm.D., BCPS, FASHP, FCCM, FCCP Professor and Regional Dean Texas Tech University Health Sciences Center School of Pharmacy Dallas, Texas

Mark Huffmyer, Pharm.D., BCACP, BCGP, CACP Assistant Professor, Department of Pharmacy Practice & Science University of Kentucky College of Pharmacy Lexington, Kentucky

Copyright © 2020, American College of Clinical Pharmacy, Inc. and American Society of Health-System Pharmacists All rights reserved.

Clinical Sessions for Recertification: Geriatric Pharmacy

** Materials for this course will be release on 12/16/2020 ** ______

Lalita Prasad-Reddy, Pharm.D., M.S., BCPS, BCACP, CDE Associate Professor of Pharmacy Practice Chicago State University College of Pharmacy Clinical Pharmacy Specialist Rush University Medical Center Chicago, Illinois

Pamela Stamm, Pharm.D., BCACP, BCPS, CDE, FASHP Associate Professor of Pharmacy Practice and Clinical Pharmacist Specialist Auburn University Harrison School of Pharmacy Central Alabama VA and Tuscaloosa VA

Kristin Zimmerman, Pharm.D. Associate Professor Virginia Commonwealth University School of Pharmacy Falls Church, Virginia

Content Matter Experts Amie Taggart Blaszczyk, Pharm.D., BCGP, BCPS, FASCP Associate Professor and Division Head – Geriatrics Texas Tech University Health Sciences Center School of Pharmacy

Dana Carroll, Pharm.D., BCGP, BCPS, CDE Clinical Professor Auburn University Harrison School of Pharmacy University of Alabama Family Medicine

Maria Shin, Pharm.D., BCGP, BCPS Clinical Pharmacy Specialist in Internal Medicine Robley Rex Louisville Veterans Affairs Medical Center

Reviewers Holly L. Byrnes, Pharm D., BCPS Susan R. Dombrowski, M.S., R.Ph. Kristi Hofer, Pharm.D. Nicholas Leon, Pharm.D., BCPS, BCACP, FCPP Michelle Hilaire Pharm.D., BCACP, BCPS, CDE, FCCP Nicole Hahn, Pharm.D., BCACP Adam Jackson, Pharm.D., BCACP Jamie L. McConaha, Pharm.D., BCACP

Field Testers TBD

Copyright © 2020, American College of Clinical Pharmacy, Inc. and American Society of Health-System Pharmacists All rights reserved.

Clinical Sessions for Recertification: Geriatric Pharmacy

** Materials for this course will be release on 12/16/2020 ** ______

Disclosures In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual of his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content.

All faculty and planners for ASHP and ACCP education activities are qualified and selected by ASHP and ACCP and required to disclose any relevant financial relationships with commercial interests. ASHP and ACCP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity.

All other planners, presenters, reviewers, ASHP and ACCP staff and others with an opportunity to control content report no financial relationships relevant to this activity.

Methods and CE Requirements Activities consist of audio/video/PDF files, an attestation statement, and activity evaluation. Learners must review all content and complete the attestation statement and course evaluation to receive continuing pharmacy education credit for each activity.

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.

System Technical Requirements Learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating web sites.

View the minimum technical and system requirements for learning activities.

Development These activities were developed by ASHP and ACCP.

Copyright © 2020, American College of Clinical Pharmacy, Inc. and American Society of Health-System Pharmacists All rights reserved.